Cleared Traditional

VZV TEST

K875358 · Gull Laboratories, Inc. · Microbiology
Mar 1988
Decision
91d
Days
Class 2
Risk

About This 510(k) Submission

K875358 is an FDA 510(k) clearance for the VZV TEST, a Antiserum, Cf, Varicella-zoster (Class II — Special Controls, product code GQX), submitted by Gull Laboratories, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on March 31, 1988, 91 days after receiving the submission on December 31, 1987. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3900.

Submission Details

510(k) Number K875358 FDA.gov
FDA Decision Cleared SESE
Date Received December 31, 1987
Decision Date March 31, 1988
Days to Decision 91 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code GQX — Antiserum, Cf, Varicella-zoster
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.3900

Similar Devices — GQX Antiserum, Cf, Varicella-zoster

All 10
VARICELLA-ZOSTER VIRUS DIRECT IMMUNOFLUORESCENCE ASSAY
K951799 · Light Diagnostics · Mar 1996
VZV IGM TEST
K911301 · Gull Laboratories, Inc. · Jul 1991
VIRGO(R) VZV-IGG ELISA
K883427 · Electro-Nucleonics, Inc. · Mar 1989
ENZYGNOST ANTI-VZV IGG TEST
K863317 · Behring Diagnostics, Inc. · Apr 1987
FIAX TEST KIT FOR VARICELLA ANTIBODY SEROLOGY
K853540 · Idt, A Division of Whittaker M.A. Bioproducts · Feb 1986
VARICELLA-ZOSTER-COMPLE FIX ANTIGEN AND NEG CONTRO
K852930 · Microbix Biosystems, Inc. · Nov 1985